I write content for the people building psychedelic-assisted therapy into something real — the clinics running ketamine programs, the companies developing the next generation of molecules, the researchers pushing the science forward.
Most copywriters in the psychedelic space fall into one of two camps: heavy on the mystical framing, or clinical to the point of lifeless. Neither serves your audience.
I'm the third option.
I've spent years studying this space — the legislation, the research, the companies, the people. I hold a KCS v6 Fundamentals certification. I've published work on AEO (how content shows up in AI-generated answers), built a chatbot case study from scratch, and spent 11+ years at Apple and CrashPlan learning how to translate complex technology into language people can actually use.
I'm not a scientist. I'm not a therapist. I'm a writer who did the reading — and can break it down for the people who need to understand it.
That's the whole pitch.
I'm not a scientist. I'm not a therapist. I'm a writer who did the reading.
For 11+ years at Apple and CrashPlan, I did the same thing I do now: took something complicated, made it less intimidating, and explained what came next.
AI is moving into psychedelic-assisted therapy — drug discovery, patient screening, session support. Some of it is real. Some is still promise. Here's what's actually happening right now.
Read at copytonics.com →Two prominent psychedelic companies rebranded in 2026 — leading with the language of pharma and psychiatry instead. Here's why the language battle matters for funding, prescribing, and the future of this field.
Read at copytonics.com →Let's work together.
Let's Work